已收录 268921 条政策
 政策提纲
  • 暂无提纲
Transient left ventricular dysfunction following chimeric antigen receptor T-cell-mediated encephalopathy: A form of stress cardiomyopathy
[摘要] Chimeric antigen receptor (CAR) T-cell therapy represents a new strategy in treating lymphoid malignancies, such as relapsed-refractory diffuse large B-cell lymphoma (DLBCL). Several toxicities including cytokine release syndrome (CRS), neurotoxicity, and cardiovascular toxicity have been linked to CAR T-cell therapy. Transient impairment in left ventricular systolic function is described after CAR-T, however, the mechanism remains poorly understood. This paper reports the clinical presentation and outcome of two patients with relapsed-refractory DLBCL who experienced encephalopathy and CRS following CAR T-cell therapy and developed transient left ventricular dysfunction consistent with stress cardiomyopathy.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 
[关键词] cardiovascular toxicity;chimeric antigen receptor T-cell therapy;cytokine release syndrome;diffuse large B-cell lymphoma;encephalopathy;stress cardiomyopathy [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文